All Stories

  1. Modification of Sexual Hormones in Rheumatoid Arthritis Patients by M2000 (β-D-mannuronic Acid) as a Novel NSAID with Immunosuppressive Property

    Article • Endocrine Metabolic & Immune Disorders - Drug Targets, August 2018, Bentham Science Publishers

    Seyed Shahabeddin Mortazavi-Jahromi, Hossein Ahmadi, Abbas Mirshafiey, Maryam Monsef Shokri

  2. The Anti-Migraine Effects of M2000 (β-D-Mannuronic Acid) on a Patient with Rheumatoid Arthritis: Case Report

    Article • Current Clinical Pharmacology, February 2018, Bentham Science Publishers

    Hossein Ahmadi, Abbas Mirshafiey, Dr Mahdi Mahmoudi

  3. The Potent Inhibitory Effect of β-D-Mannuronic Acid (M2000) as a Novel NSAID with Immunosuppressive Property on Anti-Cyclic Citrullinated Peptide Antibodies, Rheumatoid Factor and Anti-dsDNA Antibodies in Patients with Rheumatoid Arthritis

    Article • Current Drug Discovery Technologies, August 2017, Bentham Science Publishers

    Dr Mahdi Mahmoudi, Abbas Mirshafiey, Hossein Ahmadi, Salvatore Cuzzocrea

  4. Effects of β-D-mannuronic acid, as a novel non-steroidal anti-inflammatory medication within immunosuppressive properties, on IL17, RORγt, IL4 and GATA3 gene expressions in rheumatoid arthritis patients

    Article • Drug Design Development and Therapy, March 2017, Dove Medical Press

    Abbas Mirshafiey, Hossein Ahmadi